149.14999 EUR
0.25
0.17%
Last update Dec 15, 7:35 PM CET
Main market
Day range
145.050003
149.14999
Previous close
148.89999
Open
147.39999
Access this stock data via API
Subscribe
Biogen Inc.
149.15
0.25
0.17%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 8.2B 9.8B 10.2B 11.0B
Cost of revenue 2.0B 2.5B 2.3B 2.1B
Gross profit 6.3B 7.3B 7.9B 8.9B
Operating expense
Research & development 1.7B 2.5B 2.2B 2.5B
Selling general and admin 2.0B 2.5B 2.4B 2.7B
Other operating expenses 216.7M 218.8M -7.4M 7.2M
Operating income 1.9B 1.8B 2.9B 2.8B
Non operating interest income
Income 57.6M 276.5M 89.3M 11M
Expense 213.2M 246.9M 246.6M 253.6M
Other income expense -110.9M -563.9M 847.2M -820.2M
Pretax income 1.6B 1.3B 3.6B 1.7B
Tax provision 233.2M 135.3M 632.8M 52.5M
Net income 1.4B 1.2B 3.0B 1.7B
Basic EPS 11.2 8.0 21.0 10.4
Diluted EPS 11.2 8.0 20.9 10.4
Basic average shares 124.0M 150.6M 151.2M 155.2M
Diluted average shares 124.0M 150.6M 151.2M 155.2M
EBITDA 2.6B 2.6B 3.5B 3.7B
Net income from continuing op. 1.4B 1.2B 3.0B 1.7B
Minority interests 0 -400K 85.3M -171.5M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 11 hours 19 minutes

08:40
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).